Antidepressant tachyphylaxis is a distinct subtype of relapse: a patient who previously achieved a stable therapeutic response (≥50% improvement) for at least six months experiences a gradual return of symptoms — despite staying on the same medication and dose. The reflexive response is usually dose escalation or trial-and-error.
This course replaces that reflex with a systematic framework — the Tachyphylaxis Clinical Audit — to diagnose why a treatment has failed and how to strategically respond. It spans the molecular dynamics of receptor downregulation through to current pharmacological, NMDA, and neuromodulation options, built for the busy clinician who needs actionable, peer-reviewed answers.
Format note: This is a text-based course. There are no video lectures — each chapter is written to be read and referenced like a professional clinical textbook.
Included with Academy Membership
This masterclass is part of your Academy Membership — alongside 470+ clinical chapters, Journal Club, Clinical Case Discussions, the CME Academy, and the Academy Network community.
Responses